No Precision Medicine Dollars For FDA Molecular Dx Development In House Bill
This article was originally published in The Gray Sheet
Executive Summary
The House Appropriations Committee subpanel does not include any more for the FDA's portion of President Obama’s Precision Medicine Initiative to help modernize the regulatory framework for molecular diagnostics in its proposed 2016 funding measure, and would reduce the CDRH budget.